 Genital Neoplasms, Female
"Genital Neoplasms, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
| Descriptor ID |
D005833
|
| MeSH Number(s) |
C04.588.945.418 C13.351.937.418
|
| Concept/Terms |
Genital Neoplasms, Female- Genital Neoplasms, Female
- Neoplasms, Female Genital
- Gynecologic Neoplasms
- Neoplasms, Gynecologic
- Gynecologic Neoplasm
- Neoplasm, Gynecologic
- Female Genital Neoplasms
- Female Genital Neoplasm
- Genital Neoplasm, Female
- Neoplasm, Female Genital
|
Below are MeSH descriptors whose meaning is more general than "Genital Neoplasms, Female".
Below are MeSH descriptors whose meaning is more specific than "Genital Neoplasms, Female".
This graph shows the total number of publications written about "Genital Neoplasms, Female" by people in this website by year, and whether "Genital Neoplasms, Female" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 1 | 1 | 2 | | 1991 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1999 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2010 | 1 | 1 | 2 | | 2011 | 1 | 0 | 1 | | 2012 | 2 | 0 | 2 | | 2014 | 4 | 0 | 4 | | 2015 | 2 | 0 | 2 | | 2016 | 4 | 0 | 4 | | 2017 | 5 | 0 | 5 | | 2018 | 4 | 0 | 4 | | 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Genital Neoplasms, Female" by people in Profiles.
-
Kacel EL, Kirsch JL, Sannes TS, Patidar S, Postupack R, Jensen S, Wong S, Garey S, Dodd S, Ulfig CM, McCrae CS, Robinson ME, Castagno J, Schultz GS, Pereira DB. Interleukin-6 and body mass index, tobacco use, and sleep in gynecologic cancers. Health Psychol. 2019 Oct; 38(10):866-877.
-
Lefkowits C, Bevis K, Carey EC, Sheeder J, Arnold RM, Podgurski L. Gynecologic oncology providers endorse practice-changing impact of communication skills training. Gynecol Oncol. 2019 06; 153(3):633-638.
-
Alldredge J, Randall L. Germline and Somatic Tumor Testing in Gynecologic Cancer Care. Obstet Gynecol Clin North Am. 2019 Mar; 46(1):37-53.
-
Rauh-Hain JA, Brewster WR, Behbakht K. Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report. Gynecol Oncol. 2018 11; 151(2):e7-e9.
-
Ramzan AA, Behbakht K, Corr BR, Sheeder J, Guntupalli SR. Minority Race Predicts Treatment by Non-gynecologic Oncologists in Women with Gynecologic Cancer. Ann Surg Oncol. 2018 Nov; 25(12):3685-3691.
-
Ramzan AA, Fischer S, Buss MK, Urban RR, Patsner B, Duska LR, Fisher CM, Lefkowits C. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility. Gynecol Oncol. 2018 05; 149(2):401-409.
-
Lefkowits C, Buss MK, Ramzan AA, Fischer S, Urban RR, Fisher CM, Duska LR. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review. Gynecol Oncol. 2018 05; 149(2):394-400.
-
Banerji U, Dean EJ, Pérez-Fidalgo JA, Batist G, Bedard PL, You B, Westin SN, Kabos P, Garrett MD, Tall M, Ambrose H, Barrett JC, Carr TH, Cheung SYA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Elvin P, Foxley A, Lawrence P, Lindemann JPO, Maudsley R, Pass M, Rowlands V, Rugman P, Schiavon G, Yates J, Schellens JHM. A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers. Clin Cancer Res. 2018 05 01; 24(9):2050-2059.
-
Smith B, Jones EL, Kitano M, Gleisner AL, Lyell NJ, Cheng G, McCarter MD, Abdel-Misih S, Backes FJ. Influence of tumor size on outcomes following pelvic exenteration. Gynecol Oncol. 2017 11; 147(2):345-350.
-
Garcia C, Lefkowits C, Pelkofski E, Blackhall L, Duska LR. Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse. Gynecol Oncol. 2017 11; 147(2):456-459.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|